The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40
Abstract
Accumulating evidence suggests that beta-amyloid (Abeta)-induced inflammatory reactions may partially drive the pathogenesis of Alzheimer's disease (AD). Recent data also implicate similar inflammatory processes in cerebral amyloid angiopathy (CAA). To evaluate the roles of Abeta in the inflammatory processes in vascular tissues, we have tested the ability of Abeta to trigger inflammatory responses in cultured human vascular cells. We found that stimulation with Abeta dose-dependently increased the expression of CD40, and secretion of interferon-gamma (IFN-gamma) and interleukin-1beta (IL-1beta) in endothelial cells. Abeta also induced expression of IFN-gamma receptor (IFN-gammaR) both in endothelial and smooth muscle cells. Characterization of the Abeta-induced inflammatory responses in the vascular cells showed that the ligation of CD40 further increased cytokine production and/or the expression of IFN-gammaR. Moreover, IL-1beta and IFN-gamma synergistically increased the Abeta-induced expression of CD40 and IFN-gammaR. We have recently found that Abeta induces expression of adhesion molecules, and that cytokine production and interaction of CD40-CD40 ligand (CD40L) further increase the Abeta-induced expression of adhesion molecules in these same cells. These results suggest that Abeta can function as an inflammatory stimulator to activate vascular cells and induces an auto-amplified inflammatory molecular cascade, through interactions among adhesion molecules, CD40-CD40L and cytokines. Additionally, Abeta1-42, the more pathologic form of Abeta, induces much stronger effects in endothelial cells than in smooth muscle cells, while the reverse is true for Abeta1-40. Collectively, these findings support the hypothesis that the Abeta-induced inflammatory responses in vascular cells may play a significant role in the pathogenesis of CAA and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro treatment of endothelial cells with Aβ induced expression of multiple inflammatory molecules, including IFN-γ, IL-6, IL-1β, and CD40,470,471 increasing the secretion of monocyte chemoattractant, MCP-1, which has been shown to be highly expressed in the cerebral endothelial cells from AD patients.471”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [470]
Citations
Cites
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.
Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., DONNELLY, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 597
Mach, F., Schönbeck, U., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A. A., Ledbetter, J. A., Boersma, W. J., & Claassen, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2499 · Cited by 484
Geng, Y., Wu, Q. Y., Muszynski, M., Hansson, G. K., & Libby, P. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.19 · Cited by 432
Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque
Libby, P., Sukhova, G. K., Lee, R. T., & Galis, Z. S. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199500252-00003 · Cited by 371
Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J., Fabunmi, R. P., & Libby, P. (1997) · Circulation Research · doi:10.1161/01.res.81.3.448 · Cited by 334
Geng, Y., Henderson, L. E., Levesque, E. B., Muszynski, M., & Libby, P. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2200 · Cited by 266
Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 265
Research works printed but not linked: 1
- M. Tewari, V.M. Dixit, Signalling through members of the tumor necrosis factor receptor family, in: C.H. Heldin, M. Purton (Eds.), Signal Transduction, Chapman & Hall, London, 1996, pp. 79–92.
Cited by
Sorted by citations
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Gene-expression profile of the ageing brain in mice
Lee, C.-K., Weindruch, R., & Prolla, T. A. (2000) · Nature Genetics · doi:10.1038/77046 · Cited by 1,055
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Neurodegenerative disorders: the role of peroxynitrite
Torreilles, F., Salman-Tabcheh, S., Guérin, M.-C., & Torreilles, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00014-4 · Cited by 430
Metadata
- Authors
- Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., & Mullan, M.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Suo, Zhiming
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 807
- Issue
- 1-2
- Pages
- 110-117
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2052556375
- Cited by
- 116
- References
- 43
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 5 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 9 · 2013: 9 · 2012: 6
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, cerebral amyloid angiopathy, vascular inflammation, CD40, CD40 ligand, interferon-gamma, IL-1β, interferon-gamma receptor, endothelial cells, vascular smooth muscle cells, adhesion molecules, amyloid-beta 42, Aβ40, cytokine synergy
- MeSH terms
- Interferon gamma Receptor, Alzheimer Disease, Cell Line, Endothelium, Vascular, Humans, Inflammation, Interferon-gamma, Interleukin-1, Muscle, Smooth, Vascular, Signal Transduction, Up-Regulation, Cytokines, Amyloid beta-Peptides, Receptors, Interferon, Intercellular Adhesion Molecule-1, CD40 Antigens, E-Selectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review